ALS2 p.Thr386=
c.1158C>A · rs565166366 · VCV1598964
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP 5 | GERP 0.88, phastCons 1 |
| Overall | ||
| CADD | 8.898 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| South Asiangrpmax | 0.224% | 446 |
| Remaining individualsnot grpmax-eligible | 0.0048% | 20,837 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ALS2
- Protein
- p.Thr386=
- Coding
- c.1158C>A
- MANE Select
- NM_020919
- dbSNP
- rs565166366
- Type
- single nucleotide variant
- Location
- chr2:201757715 (GRCh38)
- Gene constraint
- LOEUF 0.649 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 74.69
Disease context
infantile-onset ascending hereditary spastic paralysis — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Infantile-onset ascending hereditary spastic paralysis (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Infancy, Neonatal
Similar variants
- ALS2 p.Thr386Ala Uncertain significance ★ ⚠ same residue
- ALS2 c.1640+1G>A Pathogenic/Likely pathogenic ★★ same condition
- ALS2 c.2580+2T>C Pathogenic ★★ same condition
- ALS2 c.3703-2A>G Pathogenic/Likely pathogenic ★★ same condition
- ALS2 p.Ala573Glu Likely pathogenic ★★ same condition
- ALS2 p.Arg1139Ter Pathogenic/Likely pathogenic ★★ same condition
- ALS2 p.Arg1421Ter Pathogenic/Likely pathogenic ★★ same condition
- ALS2 p.Arg1461Ter Pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/als2-p-thr386 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown